Immunobrain Unveils First Immune Checkpoint Therapy Data
19 Mar 2026 //
PR NEWSWIRE
Immunobrain To Unveil Phase 1B Data On Immune Checkpoint Therapy
13 Mar 2026 //
PR NEWSWIRE
Dr. Francis S. Collins Joins Immunobrain Board of Directors
21 Oct 2025 //
PR NEWSWIRE
ImmunoBrain Checkpoint Appoints Dr. Sanjay Keswani as Chief Executive Officer
22 Jan 2024 //
PR NEWSWIRE
First subjects in IBC’s Phase Ib trial receive IBC-Ab002
18 May 2023 //
CLINICAL TRIALS ARENA
ImmunoBrain Checkpoint Doses First Patients in Phase 1b Trial of IBC-Ab002
17 May 2023 //
PR NEWSWIRE
ImmunoBrain Awarded $5M for Phase 1b Alzheimer’s Disease of Anti-PD-L1 IBC-Ab002
27 Aug 2021 //
GLOBENEWSWIRE

Market Place
Sourcing Support